期刊文献+

肺癌A549裸鼠移植瘤模型高效建立方法的应用 被引量:2

Exploration and application of effective method to establish nude mice xenograft model of human lung cancer cells A549
下载PDF
导出
摘要 目的:探讨裸鼠高效移植瘤模型的建立方法,为进行肿瘤的体内相关研究和抗癌药物的筛选提供实验基础。方法:肺癌A549细胞接种于裸鼠皮下,出瘤后制备单细胞悬液和组织块分别接种和塞入皮下,观察初次培养细胞成瘤组、二次单细胞悬液成瘤组和二次组织块成瘤组的出瘤率和移植瘤的生长情况,PI单染流式细胞仪检测细胞周期的变化,细胞毒实验采用MTT法。结果:3组中二次组织块成瘤组的出瘤率显著高于另外两组,细胞增殖块,移植瘤的变异小;细胞周期分析显示二次组织块成瘤组的细胞S和G2/M期比例增高,细胞增殖指数显著高于另外两组;但细胞毒MTT的实验结果显示3组肿瘤细胞对化疗药物顺铂的敏感性差异无显著性(P>0.05)。结论:二次组织块成瘤可显著提高A549的成瘤率,且不影响肿瘤细胞对化疗药物的反应性,是一种高效的裸鼠移植瘤模型建立方法。 Objective:To study an effective method to establish xenograft model in nude mice.Methods:Human cancer A549 cells were subcutaneously inoculated in nude mice.After tumor formation,the single cells suspension or mini-tissue samples were prepared,inoculated and subcutaneously imbedded.Three kinds of different tumor samples were subcutaneously transplanted into nude mice.The tumor formation rate and xenograft growing characteristics were observed and analyzed.PI staining and subsequent flow cytometric analysis was used to analyze cell cycle.The cells viability was determined by MTT assay.Results:Mini-tissue samples significantly improved the xenograft formation.The percent of S and G2/M phase cells was higher in mini-tissue samples derived heterogeneous tumors by flow cytometric analysis.However,MTT results demonstrated that the cytotoxic activity of cisplatin against foregoing three group cells did not show significant difference.Conclusion:The tumor formation rate is significantly improved by mini-tissue samples without affecting the sensibility of chemotherapeutic cisplatin.Transplanting with mini-tissue samples is an effective method to establish the model of nude mice xenograft.
作者 陶黎阳 龙捷
出处 《现代医药卫生》 2011年第9期1281-1283,共3页 Journal of Modern Medicine & Health
基金 2010年度广州医学院博士 留学回国人员基金项目(编号2010C17)
关键词 肺癌 裸鼠移植瘤 动物模型 Lung cancer Nude mice xenograft Animal model
  • 相关文献

参考文献9

  • 1Collins LG, Haines C, Perkel R, et al.Lung cancer: diagnosis and management[J].Am Fam Physician, 2007,75(1) : 56.
  • 2Jemal A, Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin, 2009,59(4) : 225.
  • 3DeVita VT Jr,Chu E. A history of cancer chemotherapy[J].Cancer Res, 2008,68(21) : 8643.
  • 4Choi CH.ABC transporters as muhidrug resistance mechanisms and the development of chemosensitizers for their reversal[J].Cancer Cell Int, 2005,5:30.
  • 5Zhang JY,Tao LY,Liang YJ, et al.Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G(1) with involvement of.
  • 6Tao LY,Liang YJ,Wang F,et al. Cediranib (recentin,AZD2171) reverses ABCB1- and ABCCl-mediated muhidrug resistance by inhibition of their transport function[J].Cancer Chemother Pharmacol, 2009,64(5):961.
  • 7Tao LY ,Zhang JY, Liang Y J, et al. Anticancer effect and structureactivity analysis of marine products isolated from metabolites of mangrove fungi in the South China Sea[J].Mar Drags,8(4):1094.
  • 8王树滨,齐静,刘桂英,杨铭,杨纯正.多药耐药细胞系K562/A02裸小鼠皮下移植瘤模型的建立与鉴定[J].中国肿瘤临床,2006,33(13):721-724. 被引量:8
  • 9蒋建国,胡国华.肿瘤微环境在肿瘤淋巴转移中的作用研究进展[J].重庆医学,2010,39(9):1141-1144. 被引量:2

二级参考文献33

  • 1翟宝进,伍烽,邵泽勇,胡凯,赵纯亮,王智彪.人肝癌移植瘤多药耐药模型的建立及耐药机制的探讨[J].癌症,2004,23(8):905-909. 被引量:5
  • 2栾凤君,杨纯正.一株人红白血病多药耐药细胞系(K562/A02)的建立及其耐药特性...[J].中华肿瘤杂志,1993,15(2):101-103. 被引量:68
  • 3刘炳仁,杨纯正,栾凤君,熊冬生,刘瑞林,卞寿庚,薛艳萍,郝玉书.用逆转录-多聚酶链反应检测白血病患者多药耐药基因的表达[J].中华血液学杂志,1995,16(2):65-68. 被引量:27
  • 4Spinella F,Garrafa E,Di Castro V,et al.Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade[J].Cancer Res,2009,69(6):2669.
  • 5Banziger-Tobler NE,Halin C,Kajiya K,et al.Growth hormone promotes lymphangiogenesis[J].Am J Pathol,2008,173(2):586.
  • 6Humar B,Blair V,Charlton A,et al.E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man[J].Cancer Res,2009,69(5):2050.
  • 7Melillo G,Semenza GL.Meeting report:"exploiting the tumor microenvironment for therapeutics[J].Cancer Res,2006,66(9):4558.
  • 8Walker JL,Fourier AK,Assoian RK.Regulation 0f growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension[J].Cytokine Growth Factor Rev,2005,16(4~5):395.
  • 9Jobim FC,Schwartsmann G,Xavier NL,et al.Expression of MMP-9 and VEGF in breast cancer:correlation with other prognostic indicators[J].Rev Bras Ginecol Obstet,2008,30(6):287.
  • 10Fukumura D,Jain RK.Tumor microenvironment abnormalities:causes,consequences,and strategies to normalize[J].J Cell Biochem,2007,101(4):937.

共引文献7

同被引文献21

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部